{
  "docId": "019de517-ef27-7380-abf1-7804147a21c1",
  "docSlug": "35bb8af5e32b82874d7685e3939f2cc9",
  "documentTitle": "Bausch+Lomb | Results Presentation Deck | 39 slides",
  "authorId": "bausch-lomb",
  "authorName": "Bausch + Lomb",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-02-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 28,
  "pageCount": 39,
  "prevPage": 27,
  "nextPage": 29,
  "slideType": "revenue_buildup",
  "function": "decompose_segments",
  "density": "dense",
  "nDataPoints": 36,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de517-ef27-7380-abf1-7804147a21c1/28",
  "deckHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1",
  "deckJsonHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1.json",
  "deckAnchorHref": "/decks/019de517-ef27-7380-abf1-7804147a21c1#slide-28",
  "components": [
    {
      "bbox": {
        "h": 0.08,
        "w": 0.745,
        "x": 0.16,
        "y": 0.89
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure or ratio. See Slide 1 and this Appendix for further information on non-GAAP measures and ratios.\n2. As of the first quarter of 2023, certain products were recategorized across the consumables, implantables and equipment product categories. This change was made as management believes this better aligns these products in their respective\ncategories. Prior period presentations of product categories have been conformed to current product category structure to allow investors to evaluate results between periods on a consistent basis.\n3. Effective in the first quarter of 2023, certain products historically included in the reported results of the Pharmaceuticals segment are now included in the reported results of the Vision Care segment and certain products included in the reported\nresults of the Vision Care segment are now included in the reported results of the Pharmaceuticals segment. Management believes these movements are necessary in order to better align these products with the groupings of similar products.\nThe net impact of these product movements was not material to the periods presented. Prior period presentations of segment revenues have been conformed to the current segment reporting structure.",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c618c7f7-ba0a-4819-8566-2c6e8a4ca846",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.579,
        "w": 0.907,
        "x": 0.047,
        "y": 0.17
      },
      "kind": "table",
      "text": "Vision Care3\nContact Lens Revenue\nConsumer Revenue\nTotal Revenue\n4Q23\n$222M\n$440M\n$662M\n4Q22\n$219M\n$405M\n$624M\nReported Change\n1%\n9%\n6%\nConstant Currency Change¹\n3%\n11%\n8%\nSurgical2\nImplantables Revenue\nEquipment Revenue\nConsumables Revenue\nTotal Revenue\n4Q23\n$48M\n$52M\n$104M\n$204M\n4Q22\n$49M\n$45M\n$94M\n$188M\nReported Change\n(2%)\n16%\n11%\n9%\nConstant Currency Change¹\n0%\n13%\n7%\n7%\nPharmaceuticals3\nTotal Revenue\n4Q23\n$307M\n4Q22\n$184M\nReported Change\n67%\nConstant Currency Change¹\n66%",
      "attrs": {},
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "db5e325e-9214-435e-bd22-642c1e9881e1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.404,
        "x": 0.047,
        "y": 0.047
      },
      "kind": "title",
      "text": "Segment Reported Revenue",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6d1d27b8-50ca-4fc0-b395-07681a009eaf",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "1bde7cc9-77dd-4de9-9742-8c4de65dee21",
      "evidence": "table/data: Vision Care3 Contact Lens Revenue Consumer Revenue Total Revenue 4Q23 $222M $440M $662M 4Q22 $219M $405M $624M",
      "confidence": 0.9
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 39,
      "from": 22,
      "beatId": "8c7af079-c074-453d-8134-b8959b29a800",
      "arcName": "The Sparkline",
      "arcSlug": "sparkline",
      "beatName": "Satisfaction",
      "beatSlug": "monroes-sequence-satisfaction",
      "evidence": "The appendix and Q&A section provide satisfaction and answers to questions",
      "position": 4,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}